Advantis Corp., has acquired a 25% stake in US-based pain management and physical therapy company Sequence Therapy, LLC, which sees an exponential growth in revenue, from the current $0.5m a year, with the addition of the app-based revenue.
The acquisition will help Advantis to provide license-based digital application technology and achieve long-lasting results in the treatment of chronic pain.
Go deeper with GlobalData
Madrigal Pharmaceuticals, Inc. has announced a definitive agreement to merge with Synta Pharmaceuticals Corp.
The all-stock transaction will result in the merger of Madrigal with Synta’s wholly-owned subsidiary Saffron Merger Sub, Inc.
The merged entity will focus on developing small-molecule drugs to meet major unmet needs in cardiovascular-metabolic diseases and non-alcoholic steatohepatitis.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
